despit
incess
effort
decreas
exorbit
number
daili
death
malaria
remain
major
threat
public
health
mani
countri
transmit
anophel
mosquito
caus
infect
plasmodium
parasit
becom
resist
mani
antimalari
drug
context
seri
metalbas
compound
screen
optim
activ
differ
plasmodium
speci
strain
chapter
briefli
review
current
potenti
use
metal
complex
iron
cobalt
nickel
gallium
copper
gold
silver
metal
chelat
organometal
compound
interest
medicin
agent
greatli
benefit
fight
malaria
sulfadoxin
sulfalen
mefloquin
halofantrin
develop
boss
et
al
foley
et
al
ockenhous
et
al
nzila
et
al
recent
observ
number
plasmodium
strain
resist
drug
avail
market
increas
dramat
research
discoveri
new
antimalari
drug
becom
increasingli
necessari
emerg
countri
like
brazil
india
china
invest
extens
research
treatment
neglect
tropic
diseas
especi
malaria
chines
research
present
artemisinin
semisynthet
deriv
artemeth
arteeth
artesun
artemisin
acid
dihydroartemisin
potenti
antimalari
drug
li
et
al
princ
hayn
success
drug
treatment
malaria
due
fact
plasmodium
strain
still
littl
resist
current
statist
relat
number
malaria
death
lower
previou
decad
decreas
approxim
last
year
fig
howev
malaria
still
present
countri
estim
million
peopl
affect
diseas
case
concentr
southeast
asia
subsaharan
africa
amazon
due
tropic
subtrop
climat
favor
surviv
reproduct
anophel
mosquito
also
countri
highest
number
malaria
case
region
poor
sanitari
condit
also
favor
reproduct
develop
malaria
vector
project
roll
back
malaria
partnership
rbm
must
invest
approxim
billion
euro
wwwrollbackmalariaorg
treatment
total
erad
malaria
howev
success
initi
compromis
problem
caus
resist
plasmodium
lineag
reason
research
develop
new
antimalari
drug
must
constant
recent
metalbas
drug
activ
explor
treatment
varieti
parasit
import
effect
treatment
malaria
follow
paragraph
aim
present
stateoftheart
strategi
malaria
protozoan
infect
caus
plasmodium
p
falciparum
p
vivax
p
oval
p
malaria
p
falciparum
danger
form
diseas
due
relat
highest
rate
complic
mortal
main
vector
human
mammal
mosquito
genu
anophel
compris
speci
epidemiolog
import
mosquito
nocturn
habit
femal
feed
blood
respons
transmiss
plasmodium
rabinovitch
et
fiocruz
life
cycl
protozoan
divid
host
insect
vector
briefli
describ
illustr
schemat
fig
sting
host
sporozoit
form
plasmodium
lodg
mosquito
salivari
gland
inject
bloodstream
reach
liver
ii
hepat
cell
sporozoit
reproduc
asexu
gener
cell
call
merozoit
merozoit
reproduc
asexu
develop
sexual
iii
merozoit
destroy
erythrocyt
caus
anemia
host
initi
seri
reproduct
cycl
iv
merozoit
becom
immatur
gametocyt
precursor
male
femal
gamet
v
resting
host
stage
iiv
occur
host
cell
stage
v
vi
occur
anophel
mosquito
gametocyt
collect
matur
mosquito
digest
system
vi
fusion
gametocyt
result
zygot
also
name
ookinet
subsequ
convert
sporozoit
migrat
salivari
gland
mosquito
thu
initi
new
infecti
cycl
rabinovitch
et
al
cunico
et
al
fiocruz
knowledg
plasmodium
life
cycl
fundament
interest
select
administr
drug
treatment
infect
host
accord
korolkova
burckhalt
antimalari
commonli
use
act
evolutionari
stage
parasit
classifi
follow
blood
schizonticid
suppress
agent
drug
act
asexu
form
parasit
found
bloodstream
ii
tissu
schizonticid
drug
act
asexu
form
parasit
found
tissu
iii
gametocyt
drug
act
sexual
form
parasit
iv
sporonticid
drug
act
indirectli
veget
form
found
mosquito
vector
gametocyt
v
sporozoiticid
drug
act
form
parasit
infect
host
effect
antimalari
drug
parasit
cell
variabl
accord
infect
speci
howev
drug
may
act
hemozoin
product
inhibitor
folic
acid
synthesi
inhibitor
transcript
inhibitor
inhibitor
mitochondri
respiratori
chain
transport
protein
inhibitor
genet
materi
modifi
cunico
et
al
rai
et
al
tabl
show
main
class
antimalari
use
molecular
structur
effect
parasit
import
drug
quinolin
group
highlight
bold
structur
formula
tabl
highlight
sever
drug
especi
synthet
quinin
deriv
last
centuri
achiev
signific
space
pharmaceut
market
addit
antimalari
effect
recent
studi
shown
activ
ingredi
quinolin
deriv
present
antivir
activ
antivir
achan
et
al
wwwcureffiorg
despit
varieti
drug
use
treatment
malaria
plasmodium
speci
becom
resist
mani
compound
sibley
ringwald
report
emerg
resist
antimalari
drug
directli
relat
enorm
amount
pathogen
popul
short
time
reproduct
parasit
addit
indiscrimin
extens
use
antimalari
drug
also
contribut
process
resist
tri
solv
issu
world
health
organ
recommend
use
combin
antimalaria
drug
instead
monotherapi
mainli
artemetherlumefantrin
artesunateamodiaquin
artesunatemefloquin
artesunatesulfadoxin
artesunatepyrimethamin
cunico
et
al
vitro
studi
demonstr
compound
verapamil
desipramin
promethazin
may
revers
resist
p
falciparum
chloroquin
howev
mechan
revers
yet
known
van
schalkuyk
et
al
ridley
cunico
et
al
resist
parasit
classic
antimalari
drug
enorm
motiv
prospect
new
drug
metalbas
compound
play
import
role
context
strategi
discoveri
develop
metalbas
drug
driven
elucid
biolog
profil
parasit
identif
therapeut
target
metalloantimalari
consid
attract
new
antimalaria
agent
see
follow
topic
use
metal
therapeut
purpos
follow
advantag
possibl
prepar
stabl
complex
predict
structur
select
choic
ligand
accord
affin
increas
knowhow
metal
complex
behavior
biolog
environ
allesio
antimalari
activ
sever
metal
complex
alreadi
demonstr
prove
high
potenti
altern
treatment
resist
plasmodium
speci
biot
et
al
sala
et
al
wani
et
al
attach
metal
atom
alreadi
exist
antimalari
drug
interest
strategi
use
enhanc
efficaci
navarro
quinolinecontain
antimalari
drug
wide
use
malaria
therapi
mention
tabl
sala
et
al
chloroquin
cq
aminoquinolin
extens
use
mani
year
sharma
navarro
et
al
ruthenium
complex
wide
investig
mani
applic
medicin
exhibit
anticanc
antiallerg
antiparasit
potenti
correspond
nitric
oxid
donor
vascular
relax
induct
donnici
et
al
levina
et
al
gambino
otero
lima
et
al
seuan
et
al
correa
et
al
furrer
et
al
mazuryk
et
al
zhang
et
al
synthesi
ruthenium
complex
contain
cq
ligand
interest
strategi
improv
effect
antimalari
drug
sanchezdelgado
et
al
biot
et
al
et
al
histor
ruthenium
cq
complex
first
class
compound
investig
purpos
accord
literatur
binuclear
complex
ru
ii
chloroquin
rucqcl
complex
fig
five
time
potent
standard
chloroquin
p
berghei
p
falciparum
strain
mechan
action
complex
describ
posthydrolyt
bind
hematin
solut
inhibit
aggreg
bhematin
result
show
presenc
metal
result
significantli
enhanc
activ
cqresist
strain
sanchezdelgado
et
al
et
al
sala
et
al
sanchesdelgado
et
al
synthes
first
class
ruthenium
complex
contain
cq
ligand
vitro
experi
show
arena
ruthenium
complex
effect
cq
resist
strain
p
falciparum
areneru
ii
chloroquin
complex
fig
demonstr
appreci
antimalari
activ
addit
interact
ruthenium
deriv
target
biomolecul
investig
anoth
promis
class
chloroquin
complex
develop
therapeut
agent
gold
complex
navarro
navarro
et
al
compound
exhibit
antiparasit
potenti
treatment
leishmaniasi
trypanosomiasi
schistosomiasi
malaria
fricker
et
al
navarro
vieit
et
al
navarro
et
al
biot
et
al
antiplasmodi
potenti
gold
complex
investig
high
number
possibl
ligand
coordin
cq
chloroquin
diphosph
cqdp
allow
investig
antimalari
properti
sever
complex
navarro
vitro
test
show
gold
complex
au
pph
cq
pf
complex
fig
caus
inhibit
two
resist
strain
p
falciparum
ic
valu
nm
p
berghei
strain
studi
elucid
possibl
mechan
action
complex
includ
two
target
ie
inhibit
hemozoin
malari
pigment
dna
interact
experi
mice
show
treatment
mgkg
aucq
paral
equival
concentr
cqdp
induc
reduct
parasit
cell
respect
compar
untreat
control
result
suggest
complex
gold
cq
increas
vivo
suscept
p
berghei
cq
navarro
et
al
navarro
et
al
lead
search
novel
goldcq
complex
synthes
character
evalu
cqsentit
cqresist
strain
p
falciparum
perspect
chang
molecular
structur
au
pph
cq
pf
complex
perform
variat
counter
anion
complex
fig
phosphin
ligand
complex
fig
gold
oxid
state
au
au
iii
navarro
et
al
navarro
et
al
ii
prepar
studi
potenti
antimalari
agent
wasi
et
al
antimalari
activ
platinum
ii
complex
contain
analogu
also
consid
souza
et
al
result
indic
metal
complex
tradit
antimalari
quinolon
repres
attract
altern
develop
new
antimalari
agent
inform
review
gallium
iii
complex
new
promis
metalbas
drug
candid
lessa
et
al
mention
complex
gener
formula
clo
h
bi
activ
chloroquineresist
lineag
low
micromolar
concentr
complex
clo
complex
fig
clo
complex
fig
h
investig
respect
antimalari
activ
chloroquinesensit
chloroquineresist
p
falciparum
strain
result
reveal
complex
effect
chloroquineresist
strain
time
less
potent
chloroquineresist
strain
case
strain
complex
good
inhibitor
hemozoin
format
modest
strain
accord
author
result
suggest
due
similar
antimalari
activ
complex
gallium
iii
replac
iron
iii
biolog
environ
structureact
correl
metal
antimalari
complex
studi
seri
copper
ii
complex
contain
naphthoquinon
ligand
synthes
character
evalu
complex
exhibit
enhanc
antimalari
activ
p
falciparum
strain
furthermor
correl
antimalari
activ
metal
redox
coupl
indic
compon
parasit
electron
transport
chain
possibl
target
compound
gokhal
et
al
complex
contain
buparvaquon
gener
formula
ii
oh
ii
cu
co
ni
mn
fe
buparvaquon
studi
gokhal
et
al
copper
complex
show
better
result
demonstr
thousandfold
enhanc
antimalari
activ
parent
quinon
strain
furthermor
complex
three
time
activ
chloroquineresist
p
falciparum
strain
compar
free
ligand
experi
strain
cellular
show
fig
chemic
structur
metal
complex
antimalari
activ
reduct
parasitemia
dose
mgkg
demonstr
high
potenti
copper
complex
antimalari
agent
gokhal
et
al
antimalari
activ
gold
thiosemicarbazon
complex
complex
fig
platinum
ii
palladium
ii
complex
ligand
deriv
pyrazol
complex
fig
also
investig
complex
exhibit
better
efficaci
comparison
free
ligand
strain
p
falciparum
khany
et
al
quirant
et
al
besid
enhanc
efficaci
organ
drug
metal
complex
correspond
new
altern
treatment
malaria
inhibit
parasit
establish
vector
mosquito
recent
tapanelli
et
al
show
cu
au
ag
phosphen
complex
exhibit
notabl
activ
plasmodium
earli
sporogon
stage
result
show
metal
complex
gener
formula
l
pf
cu
ag
au
l
cl
l
thp
tri
hydroxymethyl
phosphen
pta
interfer
earli
sporogon
stage
plasmodium
inhibit
parasit
establish
vector
mosquito
microorgan
need
iron
growth
replic
crumbliss
sever
metabol
process
erythrocyt
malaria
parasit
depend
iron
heme
synthesi
dna
synthesi
proteolysi
hemoglobin
glycolysi
pentos
phosphat
shunt
mitochondri
electron
transport
co
fixat
therefor
indic
captur
iron
parasit
may
interfer
neg
metabol
sharma
strategi
correspond
interest
altern
malaria
treatment
common
ironchel
compound
siderophor
natur
produc
microorgan
acquir
iron
environ
compound
also
administ
form
free
ligand
sequestr
iron
caus
death
parasit
due
depriv
form
toxic
complex
iron
inhibit
parasit
growth
mabeza
et
al
characterist
import
effect
ironchel
hydrophilichydrophob
balanc
structur
hex
dentat
ligand
select
iron
iii
high
affin
iron
other
cation
affin
iron
main
prerequisit
antimalari
activ
ironchel
drug
valu
affin
constant
iron
iii
chelat
rang
accord
literatur
classic
chelat
desferrioxamin
dfo
complex
fig
exampl
present
affin
constant
valu
form
stabl
complex
iron
therefor
high
antimalari
activ
chelat
must
addit
affin
metal
calcium
magnesium
zinc
remov
may
detriment
parasit
goodwin
whitten
albert
lytton
et
al
ponka
et
al
cabantchik
et
al
intens
antimalari
activ
iron
chelat
correl
hydrophilichydrophob
balanc
capabl
permeat
cell
membran
scheibel
rodriguez
experiment
studi
aminotermin
deriv
desferrioxamin
show
preserv
abil
bind
iron
iii
speci
correspond
reduct
bind
iron
ii
moreov
iron
iii
form
stabl
complex
coordin
number
equal
six
mabeza
et
al
desferrioxamin
dfo
import
repres
ironchel
first
exampl
metalbas
drug
use
treat
malaria
siderophor
occur
natur
form
trihydroxam
acid
streptomyc
pilosu
use
treat
hemochromatosi
howev
inher
slow
permeat
infect
cell
restrict
advanc
stage
p
falciparum
exampl
drawback
limit
applic
model
berdouka
brittenham
structur
modif
conduct
produc
activ
lipophil
deriv
broader
effici
differ
stage
infect
cell
exampl
strategi
lipophil
complex
madfo
complex
fig
synthes
attach
nmethylanthranil
acid
nterminu
lead
higher
antimalari
activ
zincdesferrioxamin
zndfo
complex
exhibit
increas
permeabl
improv
antimalari
activ
compar
free
dfo
metal
substitut
reaction
occur
insid
erythrocyt
form
fe
iii
dfo
complex
stabl
zndfo
complex
loyevski
et
chevion
et
last
decad
antimalari
activ
ironchel
compound
investig
metal
chelat
demonstr
notabl
abil
inhibit
growth
p
falciparum
erythrocyt
pangjit
et
al
therefor
iron
chelat
correspond
promis
area
explor
obtain
effect
metalbas
drug
malaria
organometal
compound
metalcarbon
bond
r
p
provid
special
featur
classic
compound
mani
complex
electron
structur
base
valenc
electron
miessler
tarr
due
use
catalysi
applic
consider
potenti
therapi
agent
chavain
biot
first
organometal
compound
applic
medicin
salvarsan
arsphenamin
neosalvarsan
base
arsen
report
paul
ehrlich
treat
syphili
trypanosomiasi
sala
et
al
sever
organometal
complex
prepar
valu
potenti
antimalari
agent
ferrocen
exhibit
hightest
antimalari
activ
wani
et
al
ferrocen
highli
liposolubl
stabl
nontox
access
redox
potenti
make
attract
therapeut
applic
vanstaveren
metzlernolt
fouda
et
al
includ
malaria
treatment
inspir
ferrocen
sever
ferroceneconjug
analogu
structur
synthes
mefloquin
artemisia
mepacrin
quinin
atovaquon
molecul
blacki
et
al
blacki
chibal
present
moment
ferrochloroquin
ferroquin
fq
complex
fig
success
metalbas
drug
malaria
therapi
compound
describ
first
chloroquin
deriv
contain
ferrocen
molecul
incorpor
ferrocen
later
side
chain
chloroquin
biot
et
al
although
structur
similar
chloroquin
fq
vitro
activ
p
falciparum
compound
distinct
fq
high
effici
chloroquinesensit
chloroquineresist
p
falciparum
parasit
strain
reach
effici
time
higher
chloroquin
fq
exhibit
high
activ
vivo
p
yoeli
p
vinckei
p
berghei
strain
biot
et
al
evid
point
action
fq
seem
relat
inhibit
hemozoin
format
food
vacuol
parasit
despit
similar
mechan
compar
cq
studi
indic
fq
effici
cq
inhibit
format
bhematin
fq
cq
show
valu
respect
biot
et
al
ferroquin
compound
fq
success
repres
organometal
drug
sharma
biot
et
al
good
antimalari
activ
object
mani
studi
barend
et
al
biot
et
al
wani
et
al
metalbas
compound
phase
ii
clinic
test
malaria
therapi
daher
et
al
report
vitro
studi
metabol
ferroquin
anim
human
indic
potenti
applic
ferroquin
malaria
therapi
previou
interest
result
stimul
synthesi
sever
ferroquin
deriv
thiosemicarbazon
trioxaferroquin
ferrocen
dual
conjug
hydroxyferroquin
benzothiazol
wani
et
al
adam
et
al
thiosemicarbazon
tsc
correspond
import
class
compound
medicin
chemistri
leovac
et
al
interest
biolog
effect
includ
antimalari
activ
bahl
et
al
vitro
test
p
falciparum
strain
demonstr
antiplasmodi
activ
fq
conjug
thiosemicarbazon
higher
free
thiosemicarbazon
also
fqtsc
complex
fig
display
higher
fig
deriv
metal
complex
ferroquin
effici
four
plasmodium
strain
ic
valu
micromolar
rang
biot
et
al
hydroxyferroquin
deriv
also
test
wani
et
al
observ
exhibit
antiplasmodi
activ
antivir
effect
coronaviru
sever
acut
respiratori
syndrom
hydroxyferroquin
fqhydroxi
deriv
complex
fig
repres
thu
excel
altern
treat
malaria
infect
caus
coronaviru
specif
geograph
region
fqtrioxaquin
fqtrioxa
complex
fig
potenti
antiplasmodi
agent
vitro
vivo
experi
demonstr
compound
highli
effect
cqresist
strain
wani
et
al
benzothiazol
exhibit
appreci
biolog
activ
recent
adam
et
al
evalu
antimalari
activ
ferrocenylcontain
benzothiazol
complex
fig
accord
author
compound
present
antiplasmodi
activ
cqresist
cqsensit
strain
also
observ
ferroquin
deriv
abl
inhibit
format
bhematin
indic
fq
deriv
differ
mechan
action
bind
activ
pharmacophor
coval
linkag
interest
strategi
use
design
new
antimalari
agent
ferrocen
dual
conjug
advantag
strategi
fact
caus
increas
conjug
molecul
bioavail
diminish
resist
ferrocen
dual
conjug
demonstr
good
antiplasmodi
activ
meunier
develop
ferrocen
chemistri
led
investig
ruthenocen
analogu
antimalari
agent
ruthenoquin
rq
complex
fig
deriv
complex
fig
synthes
present
good
fig
ruthenoquin
deriv
compound
inhibit
p
falciparum
growth
similar
mechan
action
fq
beagley
et
al
result
avail
present
moment
point
enorm
potenti
ferroquin
deriv
develop
antiplasmodi
agent
emerg
drugresist
strain
plasmodium
spp
led
urgent
need
develop
effect
drug
metalbas
drug
consid
promis
strategi
new
antiplasmodi
agent
context
metalloantimalari
base
antimalari
drug
metal
chelat
organometal
complex
evalu
among
compound
ferroquin
success
repres
alreadi
test
phase
ii
clinic
trial
studi
physiolog
parasit
allow
understand
mechan
action
new
drug
stimul
design
new
effici
drug
studi
near
futur
expect
metallodrug
low
toxic
high
effici
found
treatment
neglect
tropic
diseas
malaria
addit
product
cost
final
product
extrem
import
factor
sinc
guarante
access
popul
poor
countri
affect
diseas
